Opportunity Information: Apply for CDC RFA PS10 1025
Apply for CDC RFA PS10 1025
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Purchase, Distribution and Tracking of Cotrimoxazole, HIV/AIDS Related Laboratory Commodities and Supplies in the Republic of Uganda Under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Jan 27, 2010 and posted on Jan 27, 2010.
- Applicants must submit their applications by Mar 30, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $60,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $9,007,459.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- National Medical Stores, Plot 4 12 Nsamizi Road, Box 16, Entebbe, Tel 256 (0414) 320542 / 320507 / 320566, Fax 256 (0414) 321323 / 321469 Direct Line 256 (0414) 322181 Email pnjala@natmedstores.org
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a CDC cooperative agreement under PEPFAR focused on strengthening Uganda's HIV/AIDS response by financing the purchase, distribution, and tracking of two essential categories of health commodities: cotrimoxazole (a key preventive and treatment-support medicine commonly used for people living with HIV to reduce opportunistic infections) and HIV/AIDS-related laboratory commodities and supplies. The practical aim is to keep critical items consistently available where they are needed most, especially at Health Center (III) facilities, which are an important level of service delivery in Uganda's health system. By backing both procurement and supply chain tracking, the program is designed to reduce stockouts, improve continuity of care, and support reliable HIV-related laboratory services that underpin diagnosis, monitoring, and treatment decisions.
The announcement was issued by the Centers for Disease Control and Prevention through its Procurement and Grants Office and was categorized as a discretionary opportunity in the health area. The funding mechanism is a cooperative agreement, which typically means CDC expects to have substantial involvement in how the project is carried out compared to a standard grant. In fiscal year 2010, CDC planned to make a single award, and the stated amount available for that award was approximately USD 9,007,459. The award floor and ceiling were both listed at USD 9,007,459, signaling that the agency anticipated one fixed-size award rather than a range of possible award amounts. While the opportunity lists an estimated total funding figure of USD 60,000,000, the specific FY2010 award described in the notice is the USD 9,007,459 amount for one recipient.
The program emphasizes national-level supply support and logistics performance, not just buying products. In other words, it is not limited to procurement; it also includes distribution and tracking, which are core supply chain functions. For cotrimoxazole, the intent is to ensure adequate national supply to meet basic HIV care and treatment needs, reflecting its role as a widely used prophylactic and supportive medication in HIV programs. For laboratory commodities, the focus is on ensuring Health Center (III) sites have the supplies required to deliver HIV-related lab services, which can include consumables and other inputs necessary for testing workflows. The underlying theme is reliability: ensuring commodities are available, moved through the system efficiently, and accounted for through tracking systems that help forecast demand and monitor stock levels.
Eligibility in this notice is narrowly defined. The eligible applicant identified is Uganda's National Medical Stores (NMS), with the opportunity referencing NMS directly and providing its contact details in Entebbe. The listing suggests this opportunity was designed for a specific implementing entity responsible for national medical supply functions, consistent with the nature of the work (national procurement and distribution). The notice also states there is no cost sharing or matching requirement, meaning the recipient would not be required to contribute a portion of project costs as a condition of the award.
Key administrative details include the funding opportunity number CDC-RFA-PS10-1025 and CFDA number 93.067 (Global AIDS). The announcement was posted on January 27, 2010, with an original and current closing date of March 30, 2010, and an archive date of April 29, 2010. For applicants or stakeholders who could not access the full announcement electronically, the notice points to the CDC PGO TIMS contact line (phone 770-488-2700) and a general email contact for assistance.
Frequently Asked Questions (FAQs)
1) What is this funding opportunity about?
This is a CDC cooperative agreement under PEPFAR focused on strengthening Uganda's HIV/AIDS response by financing the purchase, distribution, and tracking of key health commodities. It specifically supports two commodity categories: cotrimoxazole and HIV/AIDS-related laboratory commodities and supplies.
2) Which commodities are supported under this opportunity?
The opportunity supports:
- Cotrimoxazole (used as a preventive and treatment-support medicine for people living with HIV to reduce opportunistic infections).
- HIV/AIDS-related laboratory commodities and supplies (items needed to keep HIV-related laboratory testing and workflows functioning).
3) What is the practical goal of the program?
The practical goal is to keep critical HIV-related medicines and laboratory supplies consistently available where they are needed most, with particular emphasis on Health Center (III) facilities in Uganda. The program is designed to reduce stockouts, improve continuity of care, and support reliable laboratory services that inform HIV diagnosis, monitoring, and treatment decisions.
4) Is this funding only for buying products (procurement)?
No. The notice emphasizes national-level supply support and logistics performance. In addition to procurement, it includes distribution and tracking, which are core supply chain functions.
5) Why is cotrimoxazole included in the supported commodities?
Cotrimoxazole is described in the notice as a key preventive and treatment-support medicine commonly used for people living with HIV to reduce opportunistic infections. The program intent is to ensure adequate national supply to meet basic HIV care and treatment needs.
6) What is the focus for laboratory commodities and supplies?
The focus is on ensuring Health Center (III) sites have the supplies required to deliver HIV-related laboratory services. This includes consumables and other inputs necessary for testing workflows, with an emphasis on reliable availability and supply chain tracking.
7) Which level of health facilities is especially emphasized?
Health Center (III) facilities are especially emphasized as an important level of service delivery in Uganda's health system, and the program aims to keep essential commodities consistently available at this level.
8) What type of award mechanism is used?
The funding mechanism is a cooperative agreement. The notice indicates this typically means CDC expects to have substantial involvement in how the project is carried out compared to a standard grant.
9) Who issued the announcement?
The announcement was issued by the Centers for Disease Control and Prevention (CDC) through its Procurement and Grants Office.
10) How is this opportunity categorized?
It is categorized as a discretionary opportunity in the health area.
11) What is the funding opportunity number?
The funding opportunity number is CDC-RFA-PS10-1025.
12) What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.067, labeled Global AIDS.
13) How many awards were planned, and what was the expected award size?
For fiscal year 2010, CDC planned to make a single award. The amount available for that award was approximately USD 9,007,459.
14) What do the award floor and ceiling indicate?
The award floor and ceiling were both listed at USD 9,007,459. This signals the agency anticipated one fixed-size award rather than a range of possible award amounts.
15) Why does the notice mention an estimated total funding figure of USD 60,000,000?
The opportunity lists an estimated total funding figure of USD 60,000,000, but the specific FY2010 award described in the notice is USD 9,007,459 for one recipient.
16) Who is eligible to apply?
Eligibility is narrowly defined in the notice. The identified eligible applicant is Uganda's National Medical Stores (NMS), and the opportunity references NMS directly and provides its contact details in Entebbe.
17) Does this opportunity require cost sharing or matching funds?
No. The notice states there is no cost sharing or matching requirement, meaning the recipient would not be required to contribute a portion of project costs as a condition of the award.
18) When was the announcement posted?
The announcement was posted on January 27, 2010.
19) What were the closing date and archive date?
The original and current closing date listed is March 30, 2010, and the archive date is April 29, 2010.
20) What kinds of operational improvements is the program trying to achieve?
The underlying theme is reliability across the supply chain: reducing stockouts, improving continuity of care, supporting reliable HIV-related laboratory services, and strengthening tracking systems that help forecast demand and monitor stock levels.
21) What should someone do if they cannot access the full announcement electronically?
The notice directs people who cannot access the full announcement electronically to contact the CDC PGO TIMS contact line at 770-488-2700 and to use a general email contact provided for assistance.
22) What geographic program context is referenced?
The program is framed around strengthening Uganda's HIV/AIDS response, including national-level procurement and distribution functions and commodity availability at Uganda health facilities, especially Health Center (III) sites.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Investigator Initiated Multi Site Clinical Trials (Collaborative R01)
Previous opportunity: Research Grants for Preventing Violence and Violence Related Injury (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1025
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1025) also looked into and applied for these:
| Funding Opportunity |
|---|
| Investigator Initiated Multi Site Clinical Trials (Collaborative R01) Apply for PAR 10 096 Funding Number: PAR 10 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Support for a National Monitoring and Evaluation System, Strategic Information Coordination, Data Synthesis, and Data Use to Strengthen the Multi Sector HIV/AIDS Response in the United Republic of Tanzania Under PEPFAR Apply for CDC RFA PS10 1069 Funding Number: CDC RFA PS10 1069 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Support for the Ministry of Healths Monitoring and Evaluation System, Surveillance, Blood Safety and Laboratory Infrastructure in the Republic of the Ukraine under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1090 Funding Number: CDC RFA PS10 1090 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Providing HIV Prevention, Treatment, and Care Services to Injecting Drug users, Incarcerated Population, and other Vulnerable Populations in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan under PEPFAR Apply for CDC RFA PS10 10156 Funding Number: CDC RFA PS10 10156 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NEI Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) for Statistical Genetics and Genome Informatics Apply for RFA EY 10 001 Funding Number: RFA EY 10 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building the Capacity of Regional Health Management Team to Coordinate, Manage, and Support HIV/AIDS Clinical Services in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10127 Funding Number: CDC RFA PS10 10127 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Improving Access to and Delivery of HIV/AIDS Services by Strengthening Community and Health Center Linkages in the Eastern Province of the Republic of Zambia Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10108 Funding Number: CDC RFA PS10 10108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Strengthening Health Information Systems Implementation, Capacity, and Infrastructure in the Republic of Mozambique Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1086 Funding Number: CDC RFA PS10 1086 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Pediatric Pulmonary Centers (PPC) Apply for HRSA 10 103 Funding Number: HRSA 10 103 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| HIV Prevention for Most at Risk Populations (MARPs), Republic of Mozambique, Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1085 Funding Number: CDC RFA PS10 1085 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,946,000 |
| Strengthening the Blood Transfusion Services in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1079 Funding Number: CDC RFA PS10 1079 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01) Apply for RFA CE 10 006 Funding Number: RFA CE 10 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Impact of Japanese Encephalitis Vaccination in Cambodia (U01) Apply for RFA CK 10 003 Funding Number: RFA CK 10 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R03) Apply for PA 10 104 Funding Number: PA 10 104 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing and Improving HIV/AIDS Clinical Nursing Capacities and Institutional Structural Support in India Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10139 Funding Number: CDC RFA PS10 10139 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| AIDS Education and Training National Resource Center Apply for HRSA 10 131 Funding Number: HRSA 10 131 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Capacity Building to Develop Standard Electronic Client Information Data Systems Apply for HRSA 10 082 Funding Number: HRSA 10 082 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening Local Government Response to Vulnerable Children (SLGRVC) Apply for RFA 617 10 000004 Funding Number: RFA 617 10 000004 Agency: Uganda USAID Kampala Category: Health Funding Amount: $20,000,000 |
| Research on Alcohol and HIV/AIDS (R01) Apply for PA 10 103 Funding Number: PA 10 103 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R21) Apply for PA 10 105 Funding Number: PA 10 105 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1025", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.